SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015608
Filing Date
2018-08-14
Accepted
2018-08-14 16:27:31
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20180630_10q.htm 10-Q 595023
2 EXHIBIT 31.1 ex_121058.htm EX-31.1 8186
3 EXHIBIT 31.2 ex_121059.htm EX-31.2 8259
4 EXHIBIT 32.1 ex_121060.htm EX-32.1 4570
  Complete submission text file 0001437749-18-015608.txt   3170187

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20180630.xml EX-101.INS 526618
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20180630.xsd EX-101.SCH 38615
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20180630_cal.xml EX-101.CAL 24313
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20180630_def.xml EX-101.DEF 285329
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20180630_lab.xml EX-101.LAB 232471
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20180630_pre.xml EX-101.PRE 297057
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 181018001
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1